Search for: "Watson v. Industrial Commission"
Results 41 - 60
of 72
Sorted by Relevance
|
Sort by Date
8 Feb 2017, 3:09 am
Watson Laboratories, Inc., No. 16-493 (pre-AIA, do secret sales count as prior art?) [read post]
2 Jan 2014, 4:28 pm
v=j0pl_FXt0eMWilliam F. [read post]
2 Jan 2014, 4:28 pm
v=j0pl_FXt0eMWilliam F. [read post]
16 Jan 2017, 5:44 pm
Watson Laboratories, Inc., No. 16-493 (pre-AIA, do secret sales count as prior art?) [read post]
29 Aug 2022, 9:05 pm
For example, in January 2022, the FTC voted 4-0 (i.e., across party lines) to issue a complaint to block Lockheed Martin’s vertical acquisition of Aerojet Rocketdyne, in what would have been the FTC’s first defense industry merger litigation in decades.6 Several weeks later, the parties abandoned the transaction, due, in part, to the FTC’s lawsuit.7 The DOJ’s pending litigation of UnitedHealth’s proposed acquisition of Change Healthcare and… [read post]
21 May 2012, 4:54 am
The Daily Mail said that it had not commissioned the article from the freelance journalist investigating the story, although it spent four days working on the story with the journalist. [read post]
29 Aug 2011, 5:08 pm
In the Canadian case of Manson v. [read post]
8 Feb 2008, 7:00 pm
You can separately subscribe to the IP Thinktank Global week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included:Record labels sue Baidu over providing links to file-sharing sites: (Ars Technica), (Techdirt), (Out-Law), (IP Law360), (Copyfight), Merck’s Fosamax patent expires: Watson Pharmaceuticals to distribute authorized generic version, Teva and Barr also launch FDA approved generic versions: (SmartBrief), (Patent Circle),… [read post]
18 Aug 2017, 4:59 am
She later served on two federal commissions, including the Commission Appeals Board until her passing in 1950. [read post]
28 Apr 2008, 11:00 am
: (Patent Docs), US: Supreme Court declines to hear final Nucleonics’ appeal in gene-silencing patent dispute with Benitec Australia: (IP Law360), (Therapeutics Daily), US: 505(b)(2) drug approvals rock - Interaction of patents and exclusivity of drugs approved by FDA under section 505(b)(2): (Patent Baristas), US: StemCells’ patents survive reexam – StemCells and Neuralstem differ on extent of changes: (Patent Docs), US: StemCells announces issuance of… [read post]
20 Sep 2007, 12:02 pm
In re Watson, 517 F.2d 465, 472 & n.2 (Cust. [read post]
28 Dec 2015, 2:51 am
Grammy winner John Legend was one of many in the creative industries concerned that the verdict could set a worying precedent for artists creating music inspired by others. [read post]
19 Oct 2010, 1:57 am
Insured exclusion (often referred to as the I v. [read post]
10 May 2024, 6:45 am
See NCAA v. [read post]
13 Jun 2008, 3:40 am
You can separately subscribe to the IP Thinktank Global week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: ECJ rules trade mark holders cannot stop honest comparative advertising: O2 Holdings Limited and O2 (UK) Limited v Hutchinson 3G UK Limited: (Out-Law), (Catch Us If You Can!!!) [read post]
25 Mar 2011, 2:47 pm
Attention from policymakers sometimes focuses the mind of industry on what should happen. [read post]
4 Mar 2018, 4:04 pm
The Regulator has posted on the outcome of the Unsolicited Communications Enforcement Network (UCENet), which considers privacy law compliance issues in the affiliate marketing industry. [read post]
15 Dec 2010, 4:27 pm
"23 In Craven v. [read post]
18 May 2009, 5:24 am
’ (China Law Blog) Europe ECJ finds similar marks on wine and glasses not likely to cause confusion: Waterford Wedgewood plc v Assembled Investments (Proprietary) Ltd, OHIM (Class 46) (IPKat) AG Colomer opines in Maple leaf trade mark battle: joined cases American Clothing Associates SA v OHIM and OHIM v American Clothing Associates SA (IPKat) (Excess Copyright) CFI: Restitutio and time limits: how does the law stand now for CTMs? [read post]
26 Apr 2010, 1:30 pm
” He answered that “[f]ederal judges do not have roving commissions to solve societal problems. [read post]
